| Business Summary | | Infu-tech,
Inc.
provides
specialty
pharmaceuticals,
infusion
therapy
(i.e.,
administration
of
nutrients,
antibiotics
and
other
medications
either
intravenously
or
through
feeding
tubes),
and
other
medical
products
to
patients
in
their
homes,
nursing
homes
and
subacute
care
facilities.
The
Company
has
recently
launched
an
Internet
website,
Smartmeds.com,
through
which
it
plans
to
offer
health
management
applications. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | INFU
provides
clinical
services
and
products
to
patients
at
home
and
in
long
term
facilities.
These
products
include
infusion,
antibiotic
and
nutritional
therapy.
For
the
nine
months
ended
3/31/01,
revenues
fell
49%
to
$7.6
million.
Net
loss
rose
33%
to
$2.9
million.
Revenues
reflect
a
decrease
in
sales
of
Cerezyme
and
infusion
products.
Higher
loss
reflects
the
inclusion
of
a
$635
thousand
write-off
of
a
receivable
from
affiliates. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Jack Rosen, 54 Chairman | $150K | Edward Letko, 33 Pres,
CEO | -- | Frederick Schmidt, 54 CFO | 116K | Joseph Rosen, 49 VP,
Assistant Sec., Director | -- | Israel Ingberman, 54 Sec.
and Treasurer, | -- | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|